Can I take Dupixent (dupilumab) together with over‑the‑counter oral decongestants such as pseudoephedrine or phenylephrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you can safely take Dupixent (dupilumab) together with over-the-counter oral decongestants like pseudoephedrine or phenylephrine.

There are no known drug interactions or contraindications between Dupixent and oral decongestants, and they can be used concurrently without safety concerns. The FDA label for Dupixent does not list decongestants as contraindicated medications, and the only absolute contraindication is known hypersensitivity to dupilumab 1.

Key Points About This Combination

Safety Profile

  • No pharmacologic interaction exists between dupilumab (a monoclonal antibody targeting IL-4 receptor α) and sympathomimetic decongestants (α-adrenergic agonists). These medications work through completely different mechanisms and do not interfere with each other's metabolism or efficacy.

  • Real-world evidence demonstrates that patients on dupilumab commonly use concomitant medications including nasal sprays and other symptomatic treatments without adverse interactions 2.

Clinical Context

Dupilumab is approved for multiple type 2 inflammatory conditions including chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and atopic dermatitis 1, 3. Patients with these conditions frequently experience nasal congestion that may benefit from decongestant use while dupilumab addresses the underlying inflammation.

In fact, dupilumab treatment typically reduces the need for concomitant medications over time, including nasal sprays and other symptomatic treatments, as the underlying inflammatory disease comes under control 2.

Important Decongestant Considerations (Unrelated to Dupixent)

While safe to combine with Dupixent, oral decongestants have their own precautions:

Use Caution If You Have:

  • Cardiovascular disease (arrhythmias, angina, coronary artery disease, cerebrovascular disease)
  • Hypertension - pseudoephedrine causes small increases in systolic blood pressure (0.99 mmHg) and heart rate (2.83 beats/min); monitor blood pressure if hypertensive 4
  • Hyperthyroidism
  • Closed-angle glaucoma - oral decongestants may raise intraocular pressure 4
  • Bladder neck obstruction

Common Side Effects:

  • Insomnia, irritability, palpitations, loss of appetite, tremor 4
  • These effects may be additive with caffeine or stimulant medications (e.g., ADHD medications) 4

Efficacy Note:

Pseudoephedrine is more effective than phenylephrine as an oral decongestant because phenylephrine is extensively metabolized in the gut, and its efficacy has not been well established 4.

Bottom Line

Proceed with using both medications together. The combination is safe from a drug interaction standpoint. Your main considerations should be the standard precautions for decongestant use (cardiovascular status, blood pressure) rather than any concern about interaction with Dupixent. If you have nasal congestion despite being on Dupixent, oral decongestants are an appropriate symptomatic treatment option, though you may find your need for them decreases as dupilumab takes full effect over several weeks to months.

Related Questions

Is dupilumab (Dupixent) indicated for a patient with poorly controlled asthma on inhaled corticosteroid and long‑acting β2‑agonist therapy who has peripheral eosinophils 20%?
How does Dupixent (dupilumab) work?
What are the indications and dosing guidelines for Dupixent (dupilumab)?
What biologic therapy is recommended for an adult with chronic rhinosinusitis with nasal polyps (CRSwNP) driven by type II inflammation who has not achieved adequate control with maximal intranasal corticosteroids (including saline irrigation) and has had at least one prior endoscopic sinus surgery?
Can dexamethasone and dupilumab (Dupixent) be given together?
What is the recommended management for acute respiratory distress syndrome (ARDS) caused by rhinovirus or enterovirus?
How should I evaluate and manage a 36-year-old woman with one week of generalized weakness and mild headache, normal vital signs (oxygen saturation 98%, pulse 64 bpm, blood pressure 120/80 mmHg), BMI indicating overweight (weight 73 kg, height 154 cm), mild normocytic anemia (hemoglobin 11.2 g/dL, MCV 86.4 fL) and otherwise normal complete blood count?
What is the treatment timeline for an obstructing ureteral stone causing renal compromise?
How frequently are rhinovirus and enterovirus associated with acute respiratory distress syndrome?
What is the appropriate treatment for poison‑ivy dermatitis in an adult?
Should chronic thiamine supplementation be used in patients with old spinal cord injuries who do not have documented thiamine deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.